NORTH AMERICA DRUG DISCOVERY MARKET 2019-2027


MARKET OUTLOOK
A research conducted by Triton states that the North America drug discovery market will flourish with a CAGR of 8.36% in terms of revenue for the forecast period of 2019-2027.
The countries from the US and Canada together constitute the drug discovery market in the North American region.
North America is the fastest-growing region and is also expected to hold the largest share in the drug discovery market during the forecasted period. Growing lifestyle-oriented diseases, increasing spending on healthcare, and the adoption of the latest technology in cardiology are the major market drivers of the drug discovery market. In addition, the rising trend of outsourcing pharmaceutical manufacturing is anticipated to boost the contract research organizations (CROs) market. This will lead to the growth of the drug discovery market in the region.
The high cancer mortality rate has led to an increased demand for small molecule therapeutics in the Canadian drug discovery market. The country has significant infrastructure and expertise in manufacturing complex molecules for drug discovery. The growing scientific understanding of diseases at the molecular level and the discovery of genetic mutations, along with therapeutic efficacy of drug response, are also driving the market.
The Canadian Center of Drug Research and Development has been using high throughput screening (HTS) and chemical genomics in the Target ID and Validation (TIDV) process. Moreover, this extensive set of screening libraries of chemicals and natural product fractions guarantees a wide range of chemicals for drug activity. Also, for the automated detection of biological and biochemical activity, many such organizations use advanced technology like liquid-handling robots and instruments. These factors are expected to create lucrative opportunities for the drug discovery market.
COMPETITIVE OUTLOOK
Novartis International AG, Pfizer Inc., Sanofi S.A, Abbott Laboratories, Agilent Technologies, Inc., Antares Pharma, Inc., AstraZeneca plc, and Bayer AG are some of the prominent companies in the drug discovery market.
TABLE OF CONTENTS 
1. NORTH AMERICA DRUG DISCOVERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREATS OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. PESTLE OUTLOOK
2.4. REGULATORY FRAMEWORK
2.5. VALUE CHAIN OUTLOOK
2.6. MARKET ATTRACTIVENESS INDEX
2.7. KEY INSIGHT
2.8. MARKET DRIVERS
2.8.1. GROWING AGED POPULATION
2.8.2. TECHNOLOGICAL ADVANCEMENTS
2.8.3. RISE IN THE HEALTHCARE EXPENDITURE
2.8.4. SURGE IN LIFESTYLE-ORIENTED DISEASES
2.9. MARKET RESTRAINTS
2.9.1. DELAY IN PRODUCT LAUNCHES
2.9.2. RESTRICTING GROWTH RATE OF A DRUG DUE TO GENERIC DRUGS
2.10. MARKET OPPORTUNITIES
2.10.1. SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
2.10.2. RISING DEMAND FOR SPECIALTY MEDICINES
2.11. MARKET CHALLENGES
2.11.1. STRINGENT GOVERNMENT REGULATIONS
3. DRUG DISCOVERY MARKET OUTLOOK – BY DRUG TYPE
3.1. SMALL MOLECULE DRUG
3.2. BIOLOGIC DRUG
4. DRUG DISCOVERY MARKET OUTLOOK – BY TECHNOLOGY
4.1. HIGH THROUGHPUT SCREENING
4.2. BIOCHIPS
4.3. BIOINFORMATICS
4.4. PHARMACOGENOMICS AND PHARMACOGENETICS
4.5. COMBINATORIAL CHEMISTRY
4.6. NANOTECHNOLOGY
4.7. SPECTROSCOPY
4.8. METABOLOMICS
4.9. OTHER TECHNOLOGIES
5. DRUG DISCOVERY MARKET OUTLOOK – BY SERVICE
5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
5.2. CHEMICAL SERVICES
5.3. BIOLOGICAL SERVICES
5.4. OTHER PHARMACEUTICAL SERVICES
6. DRUG DISCOVERY MARKET OUTLOOK – BY END-USER
6.1. RESEARCH INSTITUTES
6.2. PHARMACEUTICAL COMPANIES
6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
6.4. OTHER END-USERS
7. DRUG DISCOVERY MARKET – REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. COUNTRY ANALYSIS
7.1.1.1. THE UNITED STATES
7.1.1.2. CANADA
8. COMPANY PROFILES
8.1. 3M COMPANY
8.2. ABBOTT LABORATORIES INC.
8.3. AGILENT TECHNOLOGIES, INC.
8.4. ANTARES PHARMA
8.5. ASTRAZENECA PLC
8.6. BAYER AG
8.7. BECTON, DICKINSON AND COMPANY (BD)
8.8. BOEHRINGER INGELHEIM
8.9. ELI LILY AND COMPANY
8.10. F. HOFFMANN-LA ROCHE LTD.
8.11. GLAXOSMITHKLINE LLC
8.12. JOHNSON & JOHNSON
8.13. MERCK & CO., INC.
8.14. NOVARTIS
8.15. PFIZER, INC.
8.16. SANOFI
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS
 
LIST OF TABLES 
TABLE 1 NORTH AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
 
 
LIST OF FIGURES 
FIGURE 1 NORTH AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)
FIGURE 3 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2027 ($ MILLION)
FIGURE 21 THE UNITED STATES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 22 CANADA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES TABLE 1 NORTH AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) TABLE 2 NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION) TABLE 3 NORTH AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION) TABLE 4 NORTH AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION) TABLE 5 NORTH AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 6 NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) LIST OF FIGURES FIGURE 1 NORTH AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 2 NORTH AMERICA DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION) FIGURE 3 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION) FIGURE 4 NORTH AMERICA DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION) FIGURE 5 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION) FIGURE 6 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION) FIGURE 7 NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION) FIGURE 8 NORTH AMERICA DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION) FIGURE 9 NORTH AMERICA DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION) FIGURE 10 NORTH AMERICA DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION) FIGURE 11 NORTH AMERICA DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION) FIGURE 12 NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION) FIGURE 13 NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION) FIGURE 14 NORTH AMERICA DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 15 NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 16 NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 17 NORTH AMERICA DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION) FIGURE 18 NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION) FIGURE 19 NORTH AMERICA DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION) FIGURE 20 NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2027 ($ MILLION) FIGURE 21 THE UNITED STATES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 22 CANADA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Other Reports by Triton Market Research

THE UNITED STATES HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The market for hair care in the United States is projected to expand with 1.14% of CAGR in the forecasting period of 2019-2025. The “ethnic hair care” category in the US is going through a massive shift. The sales of relaxants have...

INDIA HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The market for hair care in India has been anticipated to upsurge with 1.57% of CAGR in the forecasting years of 2019-2025. The middle-class population formed a significant consumer base for hair care products in the India market; this...

FRANCE HAIR CARE MARKET 2019-2025

MARKET OUTLOOK Triton Market Research speculates the France hair care market to witness -0.10% of CAGR during the forecast years of 2019-2025. The mature hair care category continued to be affected by pressure on prices, particularly in the mass dist...

CHINA HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The China hair care market is expected to display an upward trend and is estimated to grow at a CAGR of 0.94% in terms of revenue over the forecast duration of 2019 to 2025. With increasing public awareness for personal grooming and th...

BRAZIL HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The Brazilian hair care market is expected to proliferate at a CAGR of 3.18% during the forecasting period between 2019 and 2025. Salon hair care in Brazil has witnessed fast growth. Despite registering a volume decline, this category ...

Publisher: Triton Market Research